PAVmed
Healthcare, Health Care · 107 employees
PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value
Funding history
- Venture - Series Unknown — $30.0M — Feb 2026
- Series D — $45.0M — Feb 2026
- Seed — $2.7M — Feb 2025
- Venture - Series Unknown — $7.8M — Aug 2020
- Venture - Series Unknown — $4.1M — May 2020
Recent signals
- Apr 02, 2026: PAVmed Appoints Joseph Virgilio as Senior Vice President and Chief Business Officer, Medical Devices
- Feb 17, 2026: Raised $30.0M in Venture - Series Unknown
- Feb 04, 2026: Raised $45.0M in Series D
- Dec 05, 2025: SEC 8-K (5.02): On December 5, 2025, PAVmed Inc. held a special meeting of stockholders where approximately 65.8% of the voting power was present. The stockholders approved a proposal to amend the company's certificate of incorporation to effect a reverse stock split of the outstanding shares of common stock. The specific ratio for the reverse split will range from 1-for-10 to 1-for-30, with the final ratio to be determined by the board of directors. This strategic move aims to enhance the company's stock price and marketability.
- Feb 07, 2025: Raised $2.7M in Seed
- Aug 11, 2020: Raised $7.8M in Venture - Series Unknown
- May 01, 2020: Raised $4.1M in Venture - Series Unknown
- Nov 07, 2019: Raised $14.0M in Venture - Series Unknown
See plans & pricing → Track PAVmed’s funding, hiring, and signals — with verified contacts — on Fundz.